Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. MU
8. PFE
9. AWK
10. ACN

Go back to Relmada Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2021 Financial Results
(NASDAQ: RLMD) Delayed: 6.77 -0.12 (1.74%)
Previous Close $6.89    52 Week High $4.10 
Open $6.74    52 Week Low $0.87 
Day High $7.02    P/E N/A 
Day Low $6.66    EPS $0.00 
Volume 1,674,459